News
Ramipril research papers are retracted over faked data
BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5035 (Published 21 September 2015) Cite this as: BMJ 2015;351:h5035
- Michael McCarthy
- 1Seattle
Two papers that reported that the blood pressure drug ramipril was beneficial in patients with intermittent claudication due to peripheral artery disease have been retracted after an investigation found that data were fabricated by the studies’ lead author, Anna A Ahimastos, a researcher at the prestigious Baker IDI Heart and Diabetes Institute in Melbourne, Australia.
The first paper,1 published in JAMA in …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.